Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Drug maker Teva agrees to $4.3 billion national settlement over opioid lawsuits - MarketWatch
Teva Bonds: 8.8% Yield To Maturity Understates Upside (NYSE:TEVA) | Seeking Alpha
Why Teva Pharmaceutical Is Substantially More (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals Agrees To $85 Million Settlement With Oklahoma In Opioid Case | KPBS Public Media
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | MarketScreener
DEF 14A
Teva Faces Rocky Path to Recovery After Debt | Fortune
Is Teva Pharmaceutical Industries (NYSE:TEVA) Using Too Much Debt? | Nasdaq
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
Teva Reports First Quarter 2021 Financial Results | Business Wire
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Price | IL0006290147 | MarketScreener
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Teva Pharma Trends Lower Ahead Of A Key Shareholder Meeting This Week (NYSE: TEVA) | Seeking Alpha
DEF 14A
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Why Teva Pharmaceutical Is Substantially More (NYSE:TEVA) | Seeking Alpha
Teva Prepared to Fight Charges in Generics Probe If Talks Fail - Bloomberg
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
With New Teva Deal, Combined NY Settlements With Opioid Makers Top $2 Billion | New York Law Journal
Teva Reports Second Quarter 2022 Financial Results | Business Wire
New York Attorney General Letitia James secures $523 million from Teva Pharmaceuticals for role in opioid crisis | State | wktv.com
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
